title: Non-invasive evaluation of myocardial reperfusion by transthoracic Doppler echocardiography and single-photon emission computed tomography in patients with anterior acute myocardial infarction.
abstract: BACKGROUND
  The study was designed to evaluate whether the preserved coronary flow reserve (CFR) 72 hours after reperfused acute myocardial infarction (AMI) is associated with less microvascular dysfunction and is predictive of left ventricular (LV) functional recovery and the final infarct size at follow-up.
  
  
  METHODS
  In our study, CFR was assessed by transthoracic Doppler echocardiography (TDE) in 44 patients after the successful percutaneous coronary intervention during the acute AMI phase. CFR was correlated with contractile reserve assessed by low-dose dobutamine echocardiography and with the total perfusion defect measured by single-photon emission computed tomography 72 hours after reperfusion and at 5 months follow-up. The ROC analysis was performed to determine test sensitivity and specificity based on CFR. Categorical data were compared by an χ² analysis, continuous variables were analysed with the independent Student's t test. In order to analyse correlation between CFR and the parameters of LV function and perfusion, the Pearson correlation analysis was conducted. The linear regression analysis was used to assess the relationship between CFR and myocardial contractility as well as the final infarct size.
  
  
  RESULTS
  We estimated the CFR cut-off value of 1.75 as providing the maximal accuracy to distinguish between patients with preserved and impaired CFR during the acute AMI phase (sensitivity 91.7%, specificity 75%). Wall motion score index was better in the subgroup with preserved CFR as compared to the subgroup with reduced CFR: 1.74 (0.29) vs. 1.89 (0.17) (p < 0.001) during the acute phase and 1.47 (0.30) vs. 1.81 (0.20) (p < 0.001) at follow-up, respectively. LV ejection fraction was 47.78% (8.99) in preserved CFR group vs. 40.79% (7.25) in impaired CFR group (p = 0.007) 72 hours after reperfusion and 49.78% (8.70) vs. 40.36% (7.90) (p = 0.001) after 5 months at follow-up, respectively. The final infarct size was smaller in patients with preserved as compared to patients with reduced CFR: 5.26% (6.14) vs. 23.28% (12.19) (p < 0.001) at follow-up.
  
  
  CONCLUSIONS
  The early measurement of CFR by TDE can be of high value for the assessment of successful reperfusion in AMI and can be used to predict LV functional recovery, myocardial viability and the final infarct size.
authors: Department of Cardiovascular Medicine, Vilnius University Hospital Santariskiu Klinikos, Santariskiu 2, Vilnius, LT-08661, Lithuania. egle.sadauskiene@santa.lt
authors: Egle
authors: E
authors: Sadauskiene
authors: Diana
authors: D
authors: Zakarkaite
authors: Ligita
authors: L
authors: Ryliskyte
authors: Jelena
authors: J
authors: Celutkiene
authors: Alfredas
authors: A
authors: Rudys
authors: Sigita
authors: S
authors: Aidietiene
authors: Aleksandras
authors: A
authors: Laucevicius
references: Cardiovasc Ultrasound. 2005 Aug 18;3:22
references: 16107221
references: Circulation. 1992 May;85(5):1699-705
references: 1572028
references: Circulation. 1995 Aug 1;92(3):334-41
references: 7634446
references: N Engl J Med. 2007 Sep 13;357(11):1121-35
references: 17855673
references: J Am Coll Cardiol. 2000 Oct;36(4):1202-9
references: 11028471
references: Physiol Rev. 1999 Apr;79(2):609-34
references: 10221990
references: J Am Soc Echocardiogr. 2004 Jul;17(7):750-5
references: 15220900
references: J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-67
references: 2698218
references: Am J Cardiol. 1995 Nov 1;76(12):861-8
references: 7484821
references: Eur Heart J. 2001 May;22(9):729-39
references: 11350105
references: J Am Coll Cardiol. 2004 Feb 18;43(4):534-41
references: 14975460
references: J Invasive Cardiol. 2008 Nov;20(11):603-14
references: 18987402
references: Circulation. 1989 Dec;80(6 Suppl):IV17-22
references: 2513146
references: N Engl J Med. 1983 Aug 11;309(6):331-6
references: 6866068
references: Circulation. 1994 Mar;89(3):1109-17
references: 8124797
references: Heart. 2009 Nov;95(21):1732-45
references: 19276097
references: J Clin Invest. 1974 Dec;54(6):1496-508
references: 4140198
references: J Am Coll Cardiol. 1996 Dec;28(7):1712-9
references: 8962556
references: Circulation. 1998 Sep 8;98(10):1006-14
references: 9737521
references: Circulation. 1990 Sep;82(3):723-38
references: 2203553
references: Am J Cardiol. 2000 Mar 9;85(5A):50B-60B
references: 11076131
references: J Am Coll Cardiol. 1998 Nov 15;32(6):1756-64
references: 9822106
references: Am J Cardiol. 2006 Jan 1;97(1):48-54
references: 16377283
references: J Am Coll Cardiol. 2002 Sep 18;40(6):1079-84
references: 12354431
references: Circulation. 1980 Nov;62(5):945-52
references: 7418179
references: Am Heart J. 1998 Aug;136(2):335-44
references: 9704699
references: Circulation. 1995 Feb 1;91(3):656-62
references: 7828290
references: Heart. 2002 Aug;88(2):137-41
references: 12117834
references: J Am Soc Echocardiogr. 2003 Jun;16(6):607-13
references: 12778020
references: Cardiovasc Ultrasound. 2005 Mar 25;3:8
references: 15792499
references: Catheter Cardiovasc Interv. 2000 Nov;51(3):281-6
references: 11066106
references: Eur Heart J. 2007 Apr;28(7):788-97
references: 17347176
references: J Am Coll Cardiol. 2009 Jul 21;54(4):281-92
references: 19608025
references: Ann Cardiol Angeiol (Paris). 2004 Nov;53(6):325-34
references: 15603175
references: Heart. 2002 Feb;87(2):162-8
references: 11796561
references: Circulation. 1992 Jul;86(1):81-90
references: 1617793
references: Eur J Echocardiogr. 2008 Jul;9(4):415-37
references: 18579481
references: Annu Rev Physiol. 1992;54:243-56
references: 1562175
references: N Engl J Med. 2007 Feb 22;356(8):830-40
references: 17314342
references: Am J Cardiol. 2003 Feb 1;91(3):269-73
references: 12565081
references: Am J Cardiol. 1996 Nov 15;78(10):1103-8
references: 8914871
references: Circulation. 2003 Dec 2;108(22):2763-8
references: 14638543
references: J Nucl Med. 1990 Aug;31(8):1269-75
references: 2143527
references: J Am Coll Cardiol. 1994 Aug;24(2):384-91
references: 8034872
references: Eur Heart J. 2008 Dec;29(23):2909-45
references: 19004841
references: Circulation. 2004 Mar 9;109(9):1121-6
references: 14967718
references: Circulation. 1999 Jul 27;100(4):339-45
references: 10421592
references: Cardiovasc Res. 2007 Jun 1;74(3):343-55
references: 17306241
references: J Invasive Cardiol. 2008 Jul;20(7):374-9
references: 18599901
references: Eur Heart J. 2004 Sep;25(17):1526-33
references: 15342172
references: J Am Coll Cardiol. 2008 Feb 5;51(5):552-9
references: 18237684
references: Am J Cardiol. 1991 Jul 1;68(1):21-6
references: 1829319
references: J Am Coll Cardiol. 1994 Sep;24(3):624-30
references: 8077530
references: J Am Soc Echocardiogr. 2003 May;16(5):457-63
references: 12724655
references: Circulation. 1996 Jan 15;93(2):223-8
references: 8548892
references: Circ Res. 2003 Dec 12;93(12):1146-58
references: 14670830
references: Circulation. 2002 Jul 16;106(3):313-8
references: 12119246
references: Am J Cardiol. 1998 Jun 15;81(12):1491-3
references: 9645903
references: Eur Heart J. 1999 Feb;20(4):285-92
references: 10099923
references: Circulation. 2004 Mar 2;109(8):958-61
references: 14981008
references: Cardiovasc Drug Rev. 2006 Summer;24(2):116-47
references: 16961725
references: Heart. 2003 Oct;89(10):1163-8
references: 12975408
references: Eur J Echocardiogr. 2008 Jul;9(4):449-57
references: 18296409
references: Basic Res Cardiol. 2006 Sep;101(5):359-72
references: 16915531
references: Heart. 2004 Feb;90(2):123-5
references: 14729769
references: J Mol Cell Cardiol. 2007 Jan;42(1):12-8
references: 17069848
references: J Am Coll Cardiol. 2008 Feb 5;51(5):566-8
references: 18237686
references: Am Heart J. 2001 Mar;141(3):456-62
references: 11231445
references: Circulation. 2000 May 23;101(20):2368-74
references: 10821812
references: Catheter Cardiovasc Interv. 2008 Dec 1;72(7):950-7
references: 19021281